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We report the isolation of a 22-kb human gcnomic clone (G7) that contains 8 exons encoding a partial mitochondrial presequence, the entire mature 
peptide and the complete 3’ untranslated region of the E Icr mRNA of human branched-chain cr-keto acid dehydrogenase complex. Based on this 
gene structure, exon 9 contains the Tytig3 -+ Asn mutation previously identified in the EIK subunit of Mennonite and other maple syrup urine 
disease (MSUD) patients. Moreover, the homozygous mutation appears to cause skipping of exon 6 in the mutant Elu transcript. The information 
on the gene structure for the entire mature Elol subunit will facilitate investigations into the molecular basis of MSUD involving this subunit. 
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1. INTRODUCTION 
The mammalian branched-chain a-keto acid de- 
hydrogenase (BCKAD) complex catalyzes the oxidaltive 
decarboxylation of the cr-keto acids derived from 
leucine, isoleucine and valine. The mitochondrial multi- 
enzyme complex consists of three catalytic omponents: 
a branched-chain ru-keto acid decarboxylase orE 1 com- 
prised two LY (Mr = 67000) and two ,8 (MI = 37 500) 
subunits, a dihydrolipoyl transacylase or E2 with a 
24-mer structure (monomer MI = 46500) forming the 
core of the enzyme complex, and a dihydrolipoyl de- 
hydrogenase that exists as a homodimer (monomer Mr 
= 52000) and is a common component shared with 
pyruvate and a-ketoglutarate dehydrogenase complexes 
[ 11. In addition, the mammalian BCKAD complex con- 
tains two regulatory enzymes, a specific kinase and a 
specific phosphatase that control the activity of the en- 
zyme complex through reversible phosphorylation/de- 
phosphorylation mechanism [2]. 
Elc~ subunit of a compound heterozygous MSUD pa- 
tient [5]. The same mutation was later shown to be pres- 
ent in homozygous tate in MSUD patients from a Men- 
nonite population [6,7]. To facilitate analysis of muta- 
tions in MSUD affecting the Elcv subunit, we have 
undertaken the cloning of the human Elcv gene. We 
report here the gene structure for the entire mature Elcr 
subunit of the human BCKAD complex, and the precise 
skipping of an exon in the mutant Elcr transcript. 
2. MATERIALS AND METHODS 
2. I, cDNA probes 
Partial human Ela cDNA clones used in the present study were 
described previously [4]. The regions of the human Ela cDNA se- 
quence present in these cDNA clones were as follows: hEla-I 
(0.9 kb), bases 840-1783; hEla-2 (1.5 kb), bases 191-1783 and 
hEla-4 (0.2 kb), bases l-190. cDNA probes were radiolabeled by the 
random priming method [8]. 
2.2. Genontic screening and subcloning 
Maple syrup urine disease (MSUD) is an autosomal 
recessive disorder, in which the activity of the BCKAD 
complex is deficient leading to ketoacidosis, mental 
retardation and a high mortality among patients. The 
disease is genetically heterogeneous. Deficiencies in dif- 
ferent subunits of the BCKAD complex have been 
shown using cultured cells from MSUD patients j3,4]. 
A T-A transition resulting in a Tyr-Asn missense 
mutation was described by Zhang ct al. to occur in the 
A human leukocyte genomic library in AEMBL-3 (Clontech) was 
screened by plaque hybridization. Plaques producing positive signals 
were purified, and phage DNA prenxred from minilysates as describ- 
ed previously [9]. The purified phage DNA was digested with restric- 
tion enzymes, followed by fractionation in agarose gels. Exon- 
containing fragments were identified by Southern blotting analysis, 
and subcloned into the Bluescript KS vector (Stratagene). 
2.3. Nucleotide sequencing 
Cbrres/Jondrnce address: D. Chuang, Dcpartmcnt of Biocl:cmistry, 
UlliWrsitY of Texas Southwestern Medical Center, 5323 Harry I-lines 
Blvd., Dallas, ‘I-X 75235-9038, USA. Fax: (I) (214) 688.8856. 
Plasmids containing genomic DNA or cDNA inserts were obtained 
from the minipreparations of transformed E. culi XL-1 Blue cells [9]. 
Nuclrotide sequencing was carried out by the dideoxy chain termina- 
!inn method [lo] using T7 DNA polymerase (Pharmacia) on double- 
stranded tcmplatcs [ 1 l] I 
2.4. cDNA synrlresis arrd primm 
Poly(A)’ RNA was isolated from cultured fibroblasts [12) and 
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Fig. 1. Restriction map and exon organization of the human Elr~ gene. The exons (2-9) present in the G7 clone (22 kb) are represented by closed 
boxes, and numbered after the putative exon 1. Restriction fragments (horizontat bars) were generated with SolI (S). EcoRI (E) and BarnHI (B). 
cDNA synthesized and amplified by the polymerase chain reaction 
(PCR) [13]. The primers used in the amplification of different regions 
of the Elm cDNA (5’ --+3 ‘) [4] and restriction sites contained were 
as folIows: 1: CGGGGCGATCGATGCAGCGA (CM) (bases 
l-20), 1’ : CTCATAGAGGATCCGGTCCA (Brrinli I) (bases 
339-358), 2: TGCTGCAGCTCTACAAGAGCA (Psri) (bases 
300-320), 2’ : GTAACAGATGTCGACCCCTGTT (Sue (bases 
680-700), 3 : ACTCGCCACGCGGATCCCT (BumHI) (bases 
618-637), 3’ : GCTCAGCAGATAGTGCTGCTGCAG (PsrI) (bases 
1085-l 105), 4:GGGTACCACAGCACCAGTGAC (Kpnl) (bases 
99%lols), 4' : TCTCGGGGTACCTGAGGATGG (bases (Kpnl) 
1356-1376). 
3. RESULTS AND DISCUSSION 
A tota1 of 2.4 x lo6 pfu from the EMBL-3 genomic 
library were screened using hElru-1 cDNA (bases 
840-1783) as a probe. One of the positive clones (G7) 
purified contained a 22-kb insert for the Ela! gene. A 
restriction map of the entire genomic insert is shown in 
Fig. 1. Digestion of the G7 clone witfi EcoRI produced 
gene fragments of 3.3 and 5.5 kb. Hybridization with 
hEla-2 cDNA (bases 191- 1783) [4], and subsequent 
nucleotide sequencing showed that these two J!ZCORI 
fragments in combination contained the 3’ end of exon 
2 (bases 190 to 283 in the Ela, cDNA) and exons 3,4 and 
5. The EcoRI site in exon 2 was identical to the one pres- 
ent in the human E~CX cDNA [4]. Double digestion of 
the G7 clone with San and BarnHI resulted in gene 
fragments of I .7, 11.2 and 4.5 kb (Fig. 1). Wybridiza- 
tion with hEI@-4 cDNA (bases I-190) indicated that 
the 1.7 kb ~~~I-~~~~1 fragment contained exons in the 
3so 360 370 
ValMetG~uALaPheGluGlnAlaCluArgLysProLysProAs~roAsnLeuLeuPh~SerAspValTyrGlnGluMet 
acagCTGATGGA~CTTTGAGCAGGCCGAGC~~GCCC~CCCAACCCCAACCTGCTCTTCTCAGACGTGTATCAGGAGATG 1243 
380 390 
ProAlaGlnLeuArgLysGlnGlnCluSerLeuAlaArgH~sLeuGlnThrTyrGlyGluI~i~~yrProLeuAspHisPheAsp 
CCCGCCCAGCTCCGC.~GCAGCAGGAGTCGCCCCCCACCTGCAGACCTACGGGGAGCAC~ACCCACTGGATCACTTCGAT 1327 
400 
Lys*** 
AAGTGAGACCTGCTCAGCCCACCCCCACCCRTCCTCCTCAGC~ACCCC~AGAGGTA~CCCCACTCT~GGGGAGCAGGGGGACCTGA 1411 
CAGCACACCACTGTCTTCCCCAGTCAGCTCCCTCT~TACTCA~GGCCA~GGCGGCTGCCA~TCTTCACCCCTGCTCCTCC 1495 
CGGCTGTTACATTGTCAGGGGACAGCATCTGCAGCAGTTGCTGA~CTCCGTCAGCCCCCTCTTCACCTGTTGTTACAGTGCCT 1$79 
TCTCCCAGCCGCTGCGTGAC;CGCACATTCAGCACTAG~GCCCCTCTGGGCE,TGGGGTGGACATGGCAGGTCAGCCTGTGG~C 1663 
TTGCGCACGTGCGAGTCGCCAGCAGAGGTCACGAATAAACTGCATCTCTGCGCCTGGCTCTCT 1726 
Fig. 2. Nuclsulidc and &~LIWJ tllliillu acid sequences UT the ehc)m of llUlllilll Elcv yer~o. EUJII~~ seyucllccs ate in caWls, atld Ilat ciitl ill(lullir: 
SC~IICIICCS at cxon/intron boundaricsorc in lower case. Theapproximatc sizes of introns (except intron I) are indicated. The highly COnscrVCd region 
(undcrlh~cd) flanking the two phosphoscrinc (asterisk) r&dues is encoded by cxon 8. The complete 3’ ->---” end of the gene, which Includes 
the polyadenylatioa signal (AATAAA) (underlined) tcrmhlatcs at base 1726. Nuclcotide numbers arc accordine 10 IhE Ilulllan Lila CDNA 
scqlleilcc 14). 
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Fig. 3. Subclones of the amplified regions of the Elcv cDNA from a 
Mennonite MSUD patient (P.K.). Open boxes represent the coding 
region and solid lines the non-coding region of the Elm cDNA. 
Stippled boxes depict primer pairs used for PCR amplification as 
described in section 2.4. The number in parentheses indicates the 
number of subclones isolated and sequenced. The deleted exon 6 is 
shown by a peak line. The T-A conversion at base 1307 is present 
in the amplified 2-4’ region. 
5’ portion of the gene. Probing with hElcr-1 cDNA 
showed that the 4.5 kb WI-BarnHI fragment carried 
exons in the 3’ region. Further restriction analysis, 
subcloning and sequencing established that exons 2 and 
3 were located in the 1.7 kb WI-BarnHI fragment and 
exons 6,7,8, and 9 in the 4.5 kb SalI-BumHI fragment. 
The organization of exons 2 to 9 of the Elcv gene is 
depicted in Fig. 1. 
Fig. 2 shows the complete coding sequences for exons 
2-9 and exon-intron boundaries of the Elcv gene. The 
8 exons encode a partial mitochondrial presequence 
from His-(-g) to Phe-(-I), the entire mature Elcv 
subunit (Ser-1 to Lys-400) and the complete 3’ un- 
translated region including the single polyadenylation 
signal (AATAAA). The sizes of exon are as follows: ex- 
on 2 (180 bases), exon 3 (87 bases), exon 4 (109 bases), 
exon 5 (106 bases), exon 6 (206 bases), exon 7 (143 
bases), exon 8 (172 bases) and exon 9 (564 bases). The 
introns range from 106 bases (between exons 2 and 3) to 
5 kb (between exons 4 and 5) in length. All intronic 5’ 
and 3’ splice sites conform to the gt-ag rule [14]. 
The G7 clone does not contain the genomic sequence 
encoding the 5’ untranslated region of the Elcv mRNA 
that is not present in the cDNA. The upstream 
mitochondrial presequence from Gly-(-43) to Ala- 
(-10) in the Ela cDNA is also absent in the genomic 
clone (Fig. 2). These two regions are putatively encoded 
by exon 1 by analogy with the gene for thefl subunit of 
human mitochondrial ATP synthase [15]. In the past 
two years we have isolated and purified approximately 
80 additional clones from four different genomic 
libraries, but none of these clones contained the 
putative exon 1 and the 5’ flanking regions of the Elcv 
gene. The reason for the inability to clone the extreme 
5’ region is presently unknown. One possibility is that 
this region contains inverted repeats forming a 
cruciform structure, which prevents cloning in the A 
phage vector [16]. 
Based on the gene structure for the mature Elcv 
subunit, the homozygous T-A transition that causes 
MSUD in Mennonites [6,7] is present in exon 9. This 
mutation appears to affect the assembly of the Ela and 
El,0 subunits into an cr& structure (Fisher et al., in 
preparation). Moreover, during amplification of dif- 
ferent regions of the mutant Elcv cDNA from a Men- 
nonite MSUD patient (P-K.), a deletion that cor- 
responds precisely to exon 6 was found (Fig. 3). The 
deleted mutant transcript is a minor species, and ap- 
pears to be a secondary event related to the homozygous 
primary mutation. The mechanism for this exon dele- 
tion in the mutant Ela transcript remains to be 
elucidated. However, one can speculate that the 
primary mutation in exon 9 may have disruptive effects 
on the entire secondary structure of the mutant Elc~ 
pre-mRNA. Exon deletions may arise as a result of the 
failure of the splicing complex to recognize the correct 
splice site. 
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-43 -40 -30 -20 
GlyAlaIfeAlaAlaAlaArgValTrpArqLeuAs~rgGlyLeuSerGl~l~laLeuLeuLeuLe~r~lnProGlyAls 
CGGGGCGATCGCTGCAGCGAGGGTCTGGCGGCTPLAACCCCT 85 
-10 1 
ArgGlyLeuAlaArgSer XisProProArgGlnGlnGlnGlnPheSerSerLeuAspAspLysPro 
CGGGGACTGGCTAGATCT...... ..ctcttccccagCACCCCCCCAGRGGCAGCAGCAGCAGTTTTCATCTCT~ATGAC~GCCC 151 
10 20 30 
GlnPheProGlyAlaSerAlaGluPheIleAspLysLeuGluPheI~eGl~roAsnValIleSer~ly~leProIleTyrArg 
CAGTTCCCAGGGGCCTCGGCGGAGTTTATAGTTGGTCCCCATCTACCGC 235 
40 50 
ValMetAspArgGlnGlyGlnIleIleAsnProSerGluAspProHis 
GTCATGGACCGCCAAGGCCAGATCATCAACCCCCAGCGAGGACCCCCACgtgagaggcggcctcccccact~cccgtgcccccca 283 
Leu?roLysGluLysValLeu 
cgcccaggcc...../O.l kb/... CcaactgccccacgtctatctgtgcctccacccycagCTCGGTGCTG 304 
60 70 80 
LysLenTyrL:rsSerMetTrLeuLeuAsnThrMetAspArgIleLeuTyrGluSerGl~rgGln 
hRGCTCTACAAGAGCATGACACTGCTT~CACCATGGACCGCATCCTCTATGAGTCTCAGCGGCAGgtgcgtgg..../3.1 370 
90 100 
GlyArgIlePhePheTyrMetThrAsnTyrGlyGluG~uGlyThrHisValGlySerAla 
I&/...... .ccactccacccccagGGCCGGATCTCCTTCTACATGACC~CTATGGTGA~AGGGCACGCACGTGGGGAGTGCC 430 
110 
AlaAlaLeuAspAsnThrAspLeuValPheGlyGlnTyrArgGluAlaG 
GCCGCCCTGGACAACACG;ACCTGGTGTTTGGCCAGTACCGGGAGGCAGgtacgtct...../5.0 kb/......ctcctcccct 479 
120 130 140 
lyValLeuMetTyrArgAspTyrProLeuGluLeuPheMotAlaGlnCy~TyrGlyAsnIleSerAspLeuGlyL~sGly 
cctagGTGTGCTGATGTATCGGGACTACCCCCTACATCAGTGACTTGGGCAAGGGG 559 
150 160 170 
ArgGlnMetProValHisTyrGlyCysLysCluArgHi~PheVal~~~IleSerSerProLeuAlaThrGl~IlePr~G~~ 
CGCCAGATGCCTGTCCACTACGGCTGCAACCAACGCCACTTCGTCACTATCTCCTCTCCACTGGCCACGCAGATCCCTCAGGgtg 641 
la0 
laValGlyAlaAlaTyrAlaAlaLysArgAlaAsnAlaAsnArgVal 
aggat.... ./3.1 kb/..... tctcatcccctgcagCGGTGGGGGCGGCGTACGCAACAGGGTC 668 
190 200 210 
VaiIleCysTyrPheGlyGluGlyAlaALaSarGluGlyAsphlaHisAlaGlyPheAsnPh~Al~laThrLeuGluCysPro 
GTCATCTGTTACTTCCGCGAGGGGGCAGCCAGGGGGCTTCGCTGCCACACTTGAGTGCCCC 772 
220 230 
IleIlePhePheCysArgAsnAsnGlyTyrAlaIleSerThrProThrSerGluGlnTyrArgGlyAspG~yIleA 
ATCATCTTCTTCTGCCGGAACAATCGCTACGCCATCTCCACGCCCACCTCTGAGCAGTATCGCGGCGATGGCATTGgta~gggc.. 848 
240 250 
laAlaArgGlyProGl~yrGlyIleMetSerXleArgVa~A~p~lyA~~sp 
. ../0.3 kb/...... tctgtgtccccacagCAGCACGAGGCCCCGGGTATGGCATCATGTC~TCCGCG~GGATGG3~TGAT 901 
260 270 280 
ValPheAlaValTyrAsnAlaThrLysGluAlaArgArgArgAlaValAlaGluAsnGlnProPheLeuIleGluAlaMe~Thr 
GTCTTTGCCGTATACAACGCCACAAAGGAGGCCCGACGGCGGGCTGTGGCAGAG~CCAGCCCTTTCTCATCGAGGCCATG~CC 985 
290 * 300 
TyrAr ~1l~Gly~i~~i~SerThrSerAs~As~SerSerAlaTyr 
TACAGgtgcctgc...../C.2 kb/..... cttgcccctgtgcagGATCGGGCACCACAGCACCAGTGACGACAGTTC.4~CGTAC 1030 
* 310 320 
Ar~SerValAs~GluValAsnTyrTrpAsDLYsGlnAspHisProI~eSerArgLeuArgHis~yrLeuLeuSerGlnGlyTrp 
CGCTCGGTGGATGhGGTC~~T~ACTGGGAT~CAGGACChCCCC~TCTCCCGGCTGCGGCACTAT~rGCT~AG~~AA~~~~~~ 1114 
330 340 
TrpAspGluGluGlnGluLysAlaTrpArgLysGlnSerArgArgLys 
TGGGATGACCAGCAGGAGAAGGCCTGGAGTCCCGgtg~gg~~.,.. ./l.i ti/. . . ..cccatqtcccc 1162 
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